We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBP
11626
CALL
DELISTED
Huttig Building Products, Inc.
HBP
-15,900
Closed -$35K
VOLT
11627
DELISTED
Volt Information Sciences, Inc.
VOLT
-14,468
Closed -$20K
VRS
11628
DELISTED
Verso Corporation
VRS
-364,299
Closed -$3.61M
ORPH
11629
DELISTED
Orphazyme A/S
ORPH
-200,000
Closed -$2.07M
JPN
11630
DELISTED
Xtrackers Japan JPX-Nikkei 400 Equity ETF
JPN
-11,065
Closed -$320K
INFO
11631
PUT
DELISTED
IHS Markit Ltd. Common Shares
INFO
-25,500
Closed -$2M
RRD
11632
CALL
DELISTED
RR Donnelley & Sons Co.
RRD
-19,300
Closed -$28K
BXRX
11633
PUT
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
-27
Closed -$104K
CETXW
11634
DELISTED
Cemtrex Inc. Series 1 Warrant
CETXW
-12,058
Closed -$1K
TADS
11635
DELISTED
The Active Dividend Stock ETF
TADS
-31,055
Closed -$829K
BGIO
11636
DELISTED
BlackRock 2022 Global Income Opportunity Trust
BGIO
-10,475
Closed -$91K
CXP
11637
CALL
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
-16,100
Closed -$176K
ENBL
11638
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
-12,612
Closed -$64K
RAVN
11639
DELISTED
Raven Industries Inc
RAVN
-118,370
Closed -$3.11M
ADMS
11640
DELISTED
Adamas Pharmaceuticals
ADMS
-23,241
Closed -$99.5K
ECHO
11641
PUT
DELISTED
Echo Global Logistics, Inc.
ECHO
-13,200
Closed -$340K
MDLA
11642
DELISTED
Medallia, Inc.
MDLA
-624,318
Closed -$19.9M
TFLT
11643
DELISTED
Global X TargetIncome Plus 2 ETF
TFLT
-24,559
Closed -$588K
ITACU
11644
DELISTED
Industrial Tech Acquisitions, Inc. Unit
ITACU
-10,157
Closed -$102K
SBBP
11645
PUT
DELISTED
Strongbridge Biopharma plc.
SBBP
-14,500
Closed -$30K
XEC
11646
DELISTED
CIMAREX ENERGY CO
XEC
-2,512,813
Closed -$80.4M
CORE
11647
DELISTED
Core Mark Holding Co., Inc.
CORE
-33,821
Closed -$1.03M
QTS.PRB
11648
DELISTED
QTS Realty Trust, Inc. 6.50% Series B Cumulative Convertible Perpetual Preferred Stock
QTS.PRB
-100,000
Closed -$14.2M
SYKE
11649
PUT
DELISTED
SYKES Enterprises Inc
SYKE
-7,900
Closed -$270K
MXIM
11650
CALL
DELISTED
Maxim Integrated Products
MXIM
-58,000
Closed -$3.92M

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.